Emerging Roles of Nanocarrier in Cancer Therapy
About this ebook
Features
- Explains different types of nanoparticles, targeting mechanisms, and approved nanotherapeutics for oncological implications in cancer treatment.
- Covers in detail the characteristics of various nanotechnology-based drug delivery systems.
- Discusses passive and active cellular targeting, ligand-based targeting of nanoparticles, and strategies to improve nanoparticle-cellular membrane interaction.
- Presents the application of nanotherapeutics, current challenges, and prospects, and describes the path of future research.
- Highlights smart strategies for improving the clinical impact of cancer nanomedicine.
The text is primarily written for graduate students, and academic researchers in the fields of biotechnology, nanotechnology, drug delivery, pharmaceutical science, and pharmacology.
About the author
Dr Rishabha Malviya completed B. Pharmacy from Uttar Pradesh Technical University and M. Pharmacy (Pharmaceutics) from Gautam Buddha Technical University, Lucknow Uttar Pradesh. His PhD (Pharmacy) work was in the area of Novel formulation development techniques. He has more than 12.5 years of research experience and presently working as Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University since past 8 years. His area of interest includes formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery and characterization of natural polymers as pharmaceutical excipients.
Arun Kumar Singh completed his B Pharm and M Pharm from Galgotias University India.
Prof Sonali Sundram completed B. Pharm & M. Pharm (Pharmacology) from AKTU, Lucknow. She has worked as research scientist in project of ICMR in King George’s Medical University, Lucknow after that she has joined BBDNIIT and currently she is working in Galgotias University, Greater Noida, India. Her PhD (Pharmacy) work was in the area of Neurodegeneration and Nanoformulation. Her area of interest is neurodegeneration, clinical research, artificial intelligence.
